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A B S T R A C T
BACkgRound: Secundum-type atrial septal defects (ASD) are increasingly being 
treated with percutaneous placement of occluding devices. Accurate sizing of the 
ASD is mandatory for subsequent optimal selection of the device. We sought to com-
pare the two most commonly used methods, 2–dimensional transesophageal echocar-
diography (2D-TEE) and stretched- balloon sizing.
MeThodS: Sixteen patients (8 men and 8 women) aged 53.8±9.8 years with ASD were 
scheduled for implantation of an Amplatzer septal occluder device. The procedure 
was performed with the use of local only anesthesia via the right femoral vein with 
fluoroscopic guidance alone and without the intra-procedural use of 2D-TEE. The 
size of the defect was measured with 2D-TEE prior to the procedure. In the cath-
eterization laboratory the ASD size was measured again with the insertion of a sizing 
balloon inflated with diluted contrast agent until a waist appeared. Waist dimensions 
were measured using cineangiographic quantitation (QCA) software.
ReSulTS: All ASDs were successfully closed with Amplatzer occluders. A significant 
correlation was found between echocardiographic and fluoroscopic measurements of 
the ASD size (r=0.863, p=0.000). However, most of the echocardiographic measure-
ments underestimated ASD diameters compared with conventional QCA balloon siz-
ing by a mean of 3 mm (16.46±5.93 mm vs 19.83±6.3 mm, t= 4.18, p= 0.001). The 
Bland-Altman analysis evidenced a lack of agreement between echocardiographic 
and balloon sizing with 95% limits of agreement between 2.9 and -9.7 mm.
ConCluSionS: Atrial septal defects can be treated safely and effectively with the per-
cutaneous placement of an Amplatzer septal occluder device via a simple percutane-
ous technique with use of local anesthesia and fluoroscopy alone without a need for 
intra-procedural 2D-TEE. Although the use of pre-procedural 2D-TEE has been a 
common practice for establishing the diagnosis and offering an initial assessment of 
the size of the defect, it largely underestimates the latter. The single-plane fluoroscop-
ic balloon sizing performed during the procedure seems indispensable for choosing an 
occluding device of appropriate size.
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i n T R o d u C T i o n
Surgical closure of atrial septal defects (ASD) has been 
performed for decades and has been associated with very 
low morbidity and mortality rates. On the other hand, the 
placement of closure devices percutaneously via the femoral 
vein has also been used as an easy alternative approach for 
several years. Indeed, nowadays, ASDs are increasingly being 
treated by percutaneous techniques1,2 and the placement of a 
closure device is now considered as the treatment of choice 
with excellent sealing rates of the defect3. Accurate sizing 
of the ASD is mandatory for subsequent optimal selection 
of the device and can be done either by echocardiographic 
measurements (transthoracic, transesophageal or intracar-
diac) or with the use of sizing balloons in the catheterization 
laboratory. The stretched balloon measurement of the ASD 
diameter through fluoroscopy is considered the gold standard 
among them. Nevertheless, even though balloon sizing is the 
method preferred by most, an initial assessment of the ASD 
with echocardiography is usually performed in every candidate 
for percutaneous closure of the defect prior to the procedure. 
There have been numerous discussions about the potential of 
relying on echocardiography alone since this would reduce 
both the time and the cost of the procedure, but there has been 
no general consensus on this issue. We sought to evaluate two 
dimensional transesophageal echocardiography (2D-TEE) 
multi-plane measurement in comparison to single-plane 
fluoroscopic balloon sizing of the ASD in patients undergoing 
this procedure in our center.
P A T i e n T S  A n d  M e T h o d S
S T u d y  P o P u l A T i o n
Between July 2006 and June 2010, 16 patients with soli-
tary secundum-type ASD had a cardiac catheterization for 
closure of their defect with an Amplatzer Septal Occluder 
(AGA Medical Corp., Plymouth, MN) in our department. The 
patients’ characteristics are shown in Table 1. Most of them 
underwent the procedure due to a left-to-right shunt with a 
Qp/Qs ratio of  1.5 (n= 13). In all subjects, measurements of 
ASD diameters by TEE before closure were compared with 
fluoroscopic balloon sizing. for the procedure an informed 
written consent was obtained from each patient. The study 
TABle 1. Clinical, echocardiographic and procedural characteristics of the study population
n
Age 
(years) gender Symptoms indication for the procedure
echo Size 
(mm)
Balloon 
Sise (mm)
Closure 
device
Months of 
follow-up
1 63 M SOB ASD, Qp/Qs: 2.5:1 16.00 20.000 Amplatzer 24 62.00
2 31 f SOB ASD, Qp/Qs: 1.5:1 12.50 13.800 Amplatzer 16 53.00
3 44 f fatigue ASD, Qp/Qs: 3.3:1 19.00 26.00 Amplatzer 32 51.00
4 49 M DOE ASD, Qp/Qs:1.8:1 21.00 26.00 Amplatzer 28 45.00
5 65 f palpitations/PAf ASD, Qp/Qs: 2:1 12.00 20.00 Amplatzer 22 45.00
6 66 f fatigue/migraine ASD, Qp/Qs: 3:1 24.00 22.80 Amplatzer 24 45.00
7 55 f SOB ASD, Qp/Qs 2.1:1 18.00 19.00 Amplatzer 22 37.00
8 37 M SOB/weakness ASD 18.00 15.50 Amplatzer 18 36.00
9 53 f presyncope/weak ASD, Qp/Qs 1.7:1 15.00 18.00 Amplatzer 22 27.00
10 59 M SOB ASD,Qp/s1.6:1 5.00 7.80 Amplatzer 10 23.00
11 63 M CvA, DOE ASD, CvA, Qp/s1.5:1 16.00 15.50 Amplatzer 20 21.00
12 51 f fatigue/DOE ASD, RvE/PHTN, 7.00 12.00 Amplatzer 16 20.00
13 54 M CvA, DOE ASD, RvE/PHTN 11.50 20.00 Amplatzer 24 8.00
14 61 M dizzy spells ASD, Qp/s: 2:1 27.00 31.00 Amplatzer 36 5.00
15 54 M fatigue ASD, Qp/s: 1.6:1 17.00 20.00 Amplatzer 24 4.00
16 57 f SOB ASD, RvE/PHTN, Qp/s: 2.5:1 24.00 30.00 Amplatzer 32 0.00
f: female, M: male, DOE: dyspnea on exertion, PAf: paroxysmal atrial fibrillation, SOB: shortness of breath, CvA: cerebrovascular accident, ASD: 
atrial septal defect, RvE; right ventricular enlargement, PHTN: pulmonary hypertension.
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was approved by the Ethics Committee of our institution.
T R A n S e S o P h A g e A l  e C h o C A R d i o g R A P h y
Standard 2D-TEE was performed with a Philips iE 33 ul-
trasound unit (Philips Medical Systems, Bothel, Washington, 
USA) to diagnose secundum type ASDs, exclude additional 
congenital malformations and ascertain that the rims were 
sufficient for a closure device placement. Standard ASD 
measurements were carried out in the bicaval view at 60-70 
degrees and in basal short axis view. The maximum diameter 
was taken into account.
F l u o R o S C o P i C  B A l l o o n  S i z i n g  A n d 
P e R C u T A n e o u S  d e v i C e  C l o S u R e  T e C h n i q u e
In our laboratory, the procedure of percutaneous ASD 
closure is routinely performed with use of local only anesthesia 
via the right femoral vein with fluoroscopy guidance alone and 
without the intra-procedural use of TEE. All patients received 
aspirin and clopidogrel for at least 3 days prior to the proce-
dure, and prophylactic antibiotic is administered intravenously 
one hour prior to the scheduled procedure.
via a right femoral venous approach, the patients were 
catheterized and the ASD size was measured with standard 
sizing balloons with diameters between 20 and 34 mm in the 
left anterior oblique view with slight cranial angulation (30 
degrees left anterior oblique/20 degrees cranial). Sizing bal-
loons were centered in the ASD, aiming to position the distal 
half of the balloon in the left atrium and the proximal half in 
the right atrium. The balloon was inflated with diluted contrast 
agent until a waist appeared. Waist dimensions were measured 
using cineangiographic quantitation (QCA) software. The 
procedure was repeated up to two times depending on how 
well the waist was visualized. After device selection based 
on balloon measurement of ASD size, a suitable Amplatzer 
septal occluder (AGA Medical Corp., Plymouth, MN) was 
selected oversized by 2-4 mm and deployed via the special 
delivery system. The day following the procedure 2D-TEE 
was repeated to check for device position and any residual 
shunt or other peri-procedural complications. All patients 
were discharged home at 48 hours with aspirin and clopidogrel 
for 6 moths. This regimen was adopted taking into considera-
tion its safety and efficacy from the wide experience from 
coronary artery disease. At 6 moths all patients underwent 
a repeat 2D-TEE
S T A T i S T i C A l  A n A ly S e S
Data are expressed as mean ±standard deviation. Agree-
ment between methods was evaluated using paired t test and 
Pearson correlation. Calculations were based on a type I error 
level of 5%. Data were analyzed with SPSS 18 for Windows 
(SPSS Inc., Chicago, IL). Moreover, since a high correlation 
does not automatically imply that there is good agreement 
between two methods we performed also a Bland-Altman 
analysis to calculate the limits of agreement with the use 
of the statistical package MedCalc Software (Mariakerke, 
Belgium).
R e S u l T S
All ASDs were successfully closed with use of Amplatzer 
occluders. One patient developed a transient paroxysm of 
atrial fibrillation with no other periprocedural complications 
noted. At 2 weeks post-procedurally the same patient devel-
oped a brief episode of paroxysmal nocturnal dyspnea man-
aged with diuretic without further recurrences. At 6 months 
after the implantation one patient had a large residual shunt 
and at attempting to place a new closure device, the device 
migrated into the pulmonary artery and was successfully 
recaptured with a percutaneous technique. The patient was 
subsequently scheduled and underwent surgery 3 months later 
with successful closure of the ASD. Small residual shunting 
was noted in another patient at the 6-month follow-up TEE, 
who was managed conservatively. All other patients reported 
no symptoms at a mean follow-up of 30.12 ± 4.86 months.
With regards to the measurements of the ASD size ob-
tained with the TEE and the stretched balloon technique, a 
significant correlation was found between echocardiographic 
and fluoroscopic measurements (r=0.863, p=0.000) (figure 
1). However, most of the echocardiographic measurements 
underestimated ASD diameters compared with conventional 
QCA balloon sizing (16.46±5.93 mm vs 19.83 ±6.3 mm, t= 
4.18, p= 0.001) (figure 2).
Moreover, the limits of agreement between the two meth-
ods calculated with the Bland-Altman analysis, were found be-
FiguRe 1. Correlation between fluoroscopic (QCA) and echo-
cardiographic (ECHO) measurements.
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tween 2.9 and -9.7 mm. That means that 2D-TEE measurement 
may be 2.9 mm above or 9.7mm below the number obtained 
from Balloon sizing. This is a fairly wide difference suggesting 
a lack of agreement between the 2 methods (figure 3).
d i S C u S S i o n
The present study showed that 2D- TEE systematically 
underestimates stretched ASD size by at least 3 mm. This is 
reasonable since balloon-sizing technique usually stretches 
the true anatomical septal shunt measured by TEE. Two-
FiguRe 2. Atrial septal defect measured as 10.5 mm in diameter by 2-D TEE with (panel A) and without color Doppler (panel B) 
in patient No 13. In the same patient, the size of the defect was calculated at 20 mm with the stretching balloon technique in the 
catheterization laboratory. A 24 mm Amplatzer septal occluder was successfully implanted in the patient. TEE at 6 months showed 
no residual shunt. At 8 months of follow-up, the patient remains asymptomatic.
dimensional TEE provides information about the structure 
of ASD but only one cross-sectional image at a time so it 
can underestimate the ASD size4,5 if the probe is not aligned 
with the longest diameter of the defect. In addition, ASD 
changes in shape and size throughout the cardiac cycle and 
also membranous tissue usually rounds the defect and can 
easily be stretched if a balloon stretches leading to a signifi-
cant increase in the true diameter as assessed by the balloon 
method. Taking this assumption into consideration a study 
Carcagni et al6 introduced a new echocardiographic diameter. 
Apart from the classic anatomic diameter measured by 2D-
TEE, they also measured the procedural ASD diameter, using 
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as borders of the true defect the points where the thickness 
of the rims was 2.5 mm. This value was chosen from an in 
vitro observation of the thickness of the rim at the time the 
sizing balloon is inflated and the stretched balloon diameter 
is measured. In this study which included 40 patients a good 
correlation between procedural ASD diameter and stretched 
balloon diameter was found (r=0.99). The authors suggested 
that procedural diameter is easily measured, applicable to all 
echocardiographic techniques without additional cost.
We used the static balloon technique7 in which a sizing 
balloon catheter is advanced over the wire across the defect, 
and inflated with dilute contrast medium until the balloon 
has a definite waist that is visible on fluoroscopy. The balloon 
indentation can be measured by QCA as the stretched-bal-
loon-diameter by fluoroscopy.8 The same stretched-diameter 
can be measured by 2D-TEE only if the examination is per-
formed simultaneously with cardiac catheterization. The usual 
practice is to select a device 2–4 mm larger than the stretched 
ASD diameter. Devices smaller than the stretched ASD size 
cannot be deployed safely. However, issues about accuracy of 
balloon sizing emerge when the balloon is oblique through 
the defect or distends the rims.
Others have suggested that three-dimensional trans-
esophageal echocardiography (3-D TEE) can offer a better 
visualization of the anatomy of the ASD, can give accurate 
assessment of the true anatomical size, can assess tissue sur-
rounding the defect, and can follow its size during the cardiac 
cycle, providing a far better image of the defect. Even more it 
can further assist in the measurement during the stretching 
of the balloon. In the study of Maeno et al9 both 2-D and the 
3-D TEE measurements are lower than the stretching balloon 
values, with the 3-D TEE measurements having the minimal 
mean difference between the two. In a previous study10 no 
differences were observed between 3-D and stretching bal-
FiguRe 3. Bland-Altman plot indicating the limits of agree-
ment between 2-D TEE and Balloon sizing.
loon measurements. Limitation of the 3-D TEE measurement 
technique can be considered the time consuming process and 
the possibility of not capturing the region of interest during 
data acquisition, especially during the measurement of the 
stretched ASD when inflation of the balloon occurs. In addi-
tion, the need for general anesthesia with or without intubation 
and the prolonged radiation exposure should always be taken 
into consideration.
Intracardiac echocardiography (ICE) has been used for 
guiding the sizing balloon and the closure devices during 
the procedures. A recent study11 evaluated the single-plane 
balloon stretching sizing by ICE compared with the gold 
standard of fluoroscopy measurement. It was shown that ICE 
systematically underestimated the stretching balloon diameter 
by less than 1mm. Use of ICE may limit the radiation, the time 
of the procedure and the need for sedation and can always 
guide the sizing balloon in the center of the defect for offer-
ing more accurate values. The major limitations seem to be 
the single-plane view of the measurement allowing frequent 
underestimation of the size, the lack of color Doppler capabil-
ity and the high cost of the catheters. Another study which 
compared 3-D TEE both with 2-D TEE and ICE suggested 
that the former is more likely to give larger long-axis dimen-
sion and smaller short-axis dimension when compared with 
both the 2-D TEE and the ICE.12
finally, phase-contrast magnetic resonance imaging of-
fers an alternative way of noninvasive method to ASD sizing, 
especially in children with inconclusive echocardiographic 
results.13
Complications of the balloon sizing technique are rare 
in general. Oversizing of the balloon, repeated inflation or 
employment of the pull-through technique instead of the static 
one may end to tear of the atrium septum and lead to device 
embolization or entrapment. It has been suggested14 that 
inflation of the sizing balloon until flow through the shunt is 
diminished results in potentially fewer complications.
l i M i T A T i o n S  o F  T h e  S T u d y
This study was not a randomized controlled trial. It was 
rather our experience in our ASD closure program based on 
a small series of patients. This represents a major limitation 
in addition to the fact that the operators performed real time 
calculations and not off-line analysis. Nevertheless, they were 
blinded to each other’s measurements. Absolute concentric-
ity was not always achievable by balloon inflation and this 
represents another limitation since a slight underestimation 
of the balloon sizing might have occurred in some cases. On 
the other hand, over-stretching of the balloon and “over-siz-
ing” of the defect might have not been avoided in some other 
patients. However, almost all patients received a device of 
appropriate diameter since only one distal migration and no 
aortic erosions occurred. The absence of intra-procedural 
TEE that might have helped us to reduce the complication 
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rate (2 residual shunts) should also be noted. finally, we should 
emphasize that although a calculation taking into account the 
thickness of the rim of the ASD might have led to a better 
correlation with the balloon measurements, applying it to 
all ASDs was not always feasible probably due to individual 
anatomical variability.
C o n C l u S i o n S
Atrial septal defects have been treated in our cases 
safely and effectively with the percutaneous placement of an 
Amplatzer septal occluder device via a simple percutaneous 
technique with use of local anesthesia and fluoroscopy alone 
without a need for intra-procedural 2-D TEE. Although the 
use of pre-procedural 2D-TEE has been a common practice 
for establishing the diagnosis and offering an initial assessment 
of the size of the defect, it largely underestimates the latter. 
The single-plane fluoroscopic balloon sizing performed during 
the procedure seems indispensable for choosing an occluding 
device of appropriate size.
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